SCHEMBL23937800

SCHEMBL23937800

CCn1cc(C(C)=O)c2sccc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR4A2 P43354 1/20 0.40
ALDH1A1 P00352 3/20 0.38
KDM4E B2RXH2 3/20 0.38
HPGD P15428 2/20 0.38
HSD17B10 Q99714 2/20 0.38
TSHR P16473 1/20 0.38
RAB9A P51151 1/20 0.38
KMT2A Q03164 4/20 0.37
LMNA P02545 3/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
CREBBP Q92793 2/20 0.36
BRD4 O60885 1/20 0.36
CYP2C9 P11712 2/20 0.36
MAPT P10636 1/20 0.36
CYP1A2 P05177 4/20 0.35
CYP2C19 P33261 3/20 0.35
TDP1 Q9NUW8 2/20 0.35
MEN1 O00255 2/20 0.35
GAA P10253 1/20 0.35
CYP2D6 P10635 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20673904 0.86 MAP2K2 (0.41) NR4A2ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL20674231 0.83 LMNA (0.43) NR4A2ALDH1A1KDM4EHPGDRAB9A
SCHEMBL20674232 0.78 BRD4 (0.45) NR4A2ALDH1A1KDM4ERAB9AKMT2A
SCHEMBL20631059 0.78 KDM4E (0.35) ALDH1A1KDM4EKMT2ABRD4MAPT
SCHEMBL23937805 0.74 KMT2A (0.35) KMT2AGAA
SCHEMBL1497913 0.71 CNR2 (0.39) ALDH1A1KDM4EKMT2AMEN1GAA
SCHEMBL6481040 0.71 MEN1 (0.56) KMT2ALMNAMAPTMEN1GAA
SCHEMBL20673887 0.71 KMT2A (0.33) KMT2A
SCHEMBL20631038 0.71 KMT2A (0.40) ALDH1A1KDM4EHSD17B10TSHRKMT2A
SCHEMBL13564517 0.70 NR4A2 (0.69) NR4A2ALDH1A1RAB9AKMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3399968-B1 SELECTIVE INHIBITORS OF CLINICALLY IMPORTANT MUTANTS OF THE EGFR TYROSINE KINASE CS PHARMATECH LTD (KY) 2021-10-20 EP disclosed